Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Up 448.0% in January

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 6,992 shares, a growth of 448.0% from the January 15th total of 1,276 shares. Based on an average trading volume of 22,566 shares, the short-interest ratio is currently 0.3 days. Based on an average trading volume of 22,566 shares, the short-interest ratio is currently 0.3 days.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CZMWY. The Goldman Sachs Group cut shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research note on Monday, January 26th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Carl Zeiss Meditec Stock Performance

Shares of CZMWY opened at $33.47 on Wednesday. The business has a fifty day moving average of $43.49 and a 200 day moving average of $48.60. Carl Zeiss Meditec has a 52-week low of $32.02 and a 52-week high of $76.28.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.